{"id":424,"date":"2020-03-16T18:17:34","date_gmt":"2020-03-16T18:17:34","guid":{"rendered":"https:\/\/www.doctaforum-events.org\/2025\/lungcancer2025\/?page_id=424"},"modified":"2025-11-20T11:14:45","modified_gmt":"2025-11-20T11:14:45","slug":"jueves-27-de-noviembre","status":"publish","type":"page","link":"https:\/\/www.doctaforum-events.org\/2025\/lungcancer2025\/jueves-27-de-noviembre\/","title":{"rendered":"Jueves, 27 de Noviembre"},"content":{"rendered":"

<\/p>\n

\n
\n
\n
\n

08:00 – 09:15<\/h4>\n<\/div>\n
\n

SPECIAL SESSION: THORACIC SURGERY<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t

\nChairs
\n<\/span><\/td>		Dr. Miguel Congregado<\/span>
\nHospital Quironsalud Infanta Luisa, Sevilla<\/span>
\nDr. Florentino Hernando-Trancho<\/span>
\nHospital Cl\u00ednico San Carlos, Madrid<\/span><\/td>\n<\/tr>\n
08:00 - 08:15<\/td>Surgical messages from NADIM II<\/span>
\nDr. Ricard Ramos<\/span>
\nHospital Clinic Barcelona<\/span><\/td>\n<\/tr>\n
08:15 - 08:30<\/td>Surgical messages from CheckMate 816<\/span>
\nDr. Patrick Forde<\/span>
\nSt. James's Hospital, Dublin (Ireland)<\/span><\/td>\n<\/tr>\n
08:30 - 08:45<\/td>Perioperative lymph node management in chemo-immune era<\/span>
\nDr. Carlos G\u00e1lvez<\/span>
\nHospital General Univ. Dr. Balmis, Alicante<\/span><\/td>\n<\/tr>\n
08:45 - 09:00<\/td>Long-term results of a real life SECT study: segmentectomy vs. lobectomy for c-stage IA lung cancer<\/span>
\nDr. Iker L\u00f3pez<\/span>
\nHospital Univ. de Donostia<\/span><\/td>\n<\/tr>\n
09:00 - 09:15<\/td>Discussion<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

09:15 – 09:30<\/h4>\n<\/div>\n
\n

Welcome<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t
<\/td>Dr. Mariano Provencio, <\/span>
\nHospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

09:30 – 11:00<\/h4>\n<\/div>\n
\n

SESSION I: ARTIFICIAL INTELLIGENCE (AI) IN LUNG CANCER<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Chairs<\/span><\/td>Dr. Mariano Provencio<\/span>
\nHospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span>
\n Dr. Alberto Ruano<\/span>
\nUniversidad de Santiago de Compostela, A Coru\u00f1a<\/span><\/td>\n<\/tr>\n
09:30 - 09:45<\/td>AI in Real-World Data: A new horizon<\/span>
\nDr. Angela Prelaj<\/span>
\nFondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy)<\/span><\/td>\n<\/tr>\n
09:45 - 10:00<\/td>Radiomics in lung cancer applied to diagnosis and prediction<\/span>
\nDr. Mar\u00eda Jes\u00fas Ledesma-Carbayo<\/span>
\nUniversidad Polit\u00e9cnica de Madrid<\/span><\/td>\n<\/tr>\n
10:00 - 10:15<\/td>AI in digital pathology and multiplex Immunohistochemistry (IHC)<\/span>
\nDr. Sebastian Michels<\/span>
\nCologne University Hospital (Germany)<\/span><\/td>\n<\/tr>\n
10:15 - 10:30<\/td>Predicting IT with clinical and analytic data<\/span>
\nDr. Diego Chowell<\/span>
\nMount Sinai, New York (USA)<\/span><\/td>\n<\/tr>\n
10:30 - 10:45<\/td>Analyzing mutagenic events in never smokers lung cancer<\/span>
\nDr. Marcos Diaz-Gay<\/span>
\nCNIO, Centro Nacional de Investigaciones Oncol\u00f3gicas, Madrid<\/span><\/td>\n<\/tr>\n
10:45 - 11:00<\/td>Discussion<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

11:00 – 11:30<\/h4>\n<\/div>\n
\n

Coffee Break<\/h4>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n

11:30 – 12:45<\/h4>\n<\/div>\n
\n

SESSION II: STAGING AND NSCLC EARLY STAGES<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t
Chairs<\/span><\/td>Dr. Monica Anto\u00f1anzas<\/span>
\nHospital Cl\u00ednico San Carlos, Madrid<\/span>
\nDr. Ignacio Muguruza<\/span>
\nHospital Univ. Rey Juan Carlos, Madrid<\/span><\/td>\n<\/tr>\n
11:30 - 11:45<\/td>State of art. Neoadjuvant, advuvant and periadjuvant treatments<\/span>
\nDr. Ram\u00f3n Palmero<\/span>
\nICO, Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona<\/span><\/td>\n<\/tr>\n
11:45 - 12:00<\/td>Value of adjuvant therapy after neoadjuvant therapy<\/span>
\nDr. Enric Carcereny<\/span>
\nICO, Hospital Univ. Germans Trias i Pujol, Badalona, Barcelona<\/span><\/td>\n<\/tr>\n
12:00 - 12:15<\/td>Predictive factors for pCR in neoadjuvant setting<\/span>
\nDr. Tina Cascone<\/span>
\nMD Anderson Cancer Center, University of Texas (USA)<\/span><\/td>\n<\/tr>\n
12:15 - 12:30<\/td>Improving neoadjuvant strategies<\/span>
\nDr. Mariano Provencio<\/span>
\nHospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
12:30 - 12:45<\/td>Discussion<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

12:45 – 14:05<\/h4>\n<\/div>\n
\n

SESSION III: UPDATES GECP STUDIES AND CONSENSUS<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Chairs<\/span><\/td>Dr. Pilar Diz<\/span>
\n Hospital Univ. de Le\u00f3n<\/span>
\n Dr. Alfredo S\u00e1nchez<\/span>
\n Hospital Provincial de Castell\u00f3n<\/span><\/td>\n<\/tr>\n
12:45 - 12:55<\/td>SLCG studies: Early stages NSCLC<\/span>
\n Dr. Alejandro Olivares<\/span>
\n Hospital Univ.de Salamanca<\/span><\/td>\n<\/tr>\n
12:55 - 13:05<\/td>SLCG studies: Advanced\u00a0stages NSCLC<\/span>
\n Dr. Laia Vil\u00e0<\/span>
\n Hospital Parc Taul\u00ed, Barcelona<\/span><\/td>\n<\/tr>\n
13:05 - 13:15<\/td>SLCG studies: Other thoracic tumors and pharmacogenomics studies<\/span>
\n Dr. Carlos Aguado<\/span>
\n Hospital Cl\u00ednico San Carlos, Madrid<\/span><\/td>\n<\/tr>\n
13:15 - 13:25<\/td>SLCG studies: Registries and database<\/span>
\n Dr. Karla Medina<\/span>
\n Hospital Univ. Ntra. Sra. de Candelaria, Santa Cruz de Tenerife<\/span><\/td>\n<\/tr>\n
13:25 - 13:35<\/td>Long-term survivors in metastatic lung cancer consensus<\/span>
\n Dr. Ana Laura Ortega<\/span>
\n Hospital Univ. de Ja\u00e9n<\/span><\/td>\n<\/tr>\n
13:35 - 13:45<\/td>Multidisciplinary approach for patients with early and locally advanced non-small cell lung cancer (NSCLC). 2nd SLCG consensus<\/span>
\n Dr. Natividad Mart\u00ednez<\/span>
\n Hospital General Univ. Dr. Balmis, Alicante<\/span><\/td>\n<\/tr>\n
13:45 - 13:55<\/td>SLCG consensus: Multidisciplinary approach of sexual dysfunction in patients with lung cancer<\/span>
\n Dr. Vanessa Ospina<\/span>
\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
13:55 - 14:05<\/td>Discussion<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

14:05 – 15:30<\/h4>\n<\/div>\n
\n

Lunch<\/h4>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n

14:05 – 15:30<\/h4>\n<\/div>\n
\n

LUNCH SATELLITE SYMPOSIUM<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t
Sponsored by BMS<\/span><\/td>Making academic research a reality: Keys to success in collaborative studies between scientific societies and the pharmaceutical industry<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

15:30 – 16:45<\/h4>\n<\/div>\n
\n

SESSION IV: LOCOREGIONAL NSCLC DISEASE<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t
Chairs<\/span><\/td> Dr. Hugo Arasanz<\/span>
\n Hospital Univ. de Navarra<\/span>
\n Dr. Juan Coves<\/span>
\n Hospital Son Ll\u00e0tzer, Palma de Mallorca<\/span><\/td>\n<\/tr>\n
15:30 - 15:45<\/td>Induction treatment previously to RT\/CT<\/span>
\n Dr. Virginia Calvo<\/span>
\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
15:45 - 16:00<\/td>Feasibility concomitant immunotherapy and radiotherapy<\/span>
\n Dr. Reyes Bernab\u00e9<\/span>
\n Hospital Univ. Virgen del Roc\u00edo, Sevilla<\/span><\/td>\n<\/tr>\n
16:00 - 16:15<\/td> Is there a role for SBRT?<\/span>
\n Dr. Javier Luna<\/span>
\n Hospital Univ. Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid<\/span><\/td>\n<\/tr>\n
16:15 - 16:30<\/td>Treatment strategies for locoregional disease with oncogenic driver<\/span>
\n Dr. Patricia Iranzo<\/span>
\n Hospital Univ. Vall d'Hebron, Barcelona<\/span><\/td>\n<\/tr>\n
16:30 - 16:45<\/td>Discussion<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

16:45 – 18:00<\/h4>\n<\/div>\n
\n

SESSION V: DNA AND LIQUID BIOPSY<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t
Chairs<\/span><\/td>Dr. Alberto Cruz<\/span>
\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span>
\n Dr. Paula Espinosa<\/span>
\n Hospital Cl\u00ednic General Univ. de Valencia<\/span><\/td>\n<\/tr>\n
16:45 - 17:00<\/td>Pitfalls of liquid biopsy<\/span>
\n Dr. Atocha Romero<\/span>
\n Hospital Univ. Puerta de Hierro, Majadahonda, Madrid<\/span><\/td>\n<\/tr>\n
17:00 - 17:15<\/td>Assessment of MRD<\/span>
\n Dr. Margarita Majem<\/span>
\n Hospital de la Santa Creu i Sant Pau, Barcelona<\/span><\/td>\n<\/tr>\n
17:15 - 17:30<\/td>Monitoring response in oncogenic drivers<\/span>
\n Dr. Manuel Cobo<\/span>
\n Hospital Regional Univ. de M\u00e1laga<\/span><\/td>\n<\/tr>\n
17:30 - 17:45<\/td>New developments in liquid biopsy<\/span>
\n Dr. Valeria Denninghoff<\/span>
\n GENYO - Centro de Gen\u00f3mica e Investigaci\u00f3n Oncol\u00f3gica, Granada<\/span><\/td>\n<\/tr>\n
17:45 - 18:00<\/td>Discussion<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

18:00 – 19:00<\/h4>\n<\/div>\n
\n

SESSION VI: EGFR DISEASE<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t\n\t\n\t\n\t\n\t
Chairs<\/span><\/td>Dr. Aitor Azkarate<\/span>
\n Hospital Univ. Son Espases, Palma de Mallorca<\/span>
\n Dr. Patricia Cruz<\/span>
\n Hospital General Univ. de Ciudad Real<\/span><\/td>\n<\/tr>\n
18:00 - 18:15<\/td>Treatment decisions in unfrequent mutations<\/span>
\n Dr. Rafael L\u00f3pez<\/span>
\n Hospital Cl\u00ednico Univ. de Valladolid<\/span><\/td>\n<\/tr>\n
18:15 - 18:30<\/td>Debate: Pros and Cons combination EGFR treatments - Pros<\/span>
\n Dr. Bartomeu Massut\u00ed<\/span>
\n Hospital General Univ. Dr. Balmis, Alicante<\/span><\/td>\n<\/tr>\n
18:30 - 18:45<\/td>Debate: Pros and Cons combination EGFR treatments - Cons<\/span>
\n Dr. Jos\u00e9 Luis Gonz\u00e1lez Larriba<\/span>
\n Hospital Cl\u00ednico San Carlos, Madrid<\/span><\/td>\n<\/tr>\n
18:45 - 19:00<\/td>Discussion<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
\n
\n
\n

19:00 – 20:00<\/h4>\n<\/div>\n
\n

SATELLITE SYMPOSIUM<\/h4>\n<\/div>\n<\/div>\n
\n\n\n\n\t
Sponsored by Johnson & Johnson<\/span><\/td>Navigating the treatment journey for EGFR+ NSCLC<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

08:00 – 09:15 SPECIAL SESSION: THORACIC SURGERY 09:15 – 09:30 Welcome 09:30 – 11:00 SESSION I: ARTIFICIAL INTELLIGENCE (AI) IN LUNG CANCER 11:00 – 11:30 Coffee Break 11:30 – 12:45 SESSION II: STAGING AND NSCLC EARLY STAGES 12:45 – 14:05 SESSION III: UPDATES GECP STUDIES AND CONSENSUS 14:05 – 15:30 Lunch 14:05 – 15:30 LUNCH […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-424","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.doctaforum-events.org\/2025\/lungcancer2025\/wp-json\/wp\/v2\/pages\/424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.doctaforum-events.org\/2025\/lungcancer2025\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.doctaforum-events.org\/2025\/lungcancer2025\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2025\/lungcancer2025\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.doctaforum-events.org\/2025\/lungcancer2025\/wp-json\/wp\/v2\/comments?post=424"}],"version-history":[{"count":84,"href":"https:\/\/www.doctaforum-events.org\/2025\/lungcancer2025\/wp-json\/wp\/v2\/pages\/424\/revisions"}],"predecessor-version":[{"id":1536,"href":"https:\/\/www.doctaforum-events.org\/2025\/lungcancer2025\/wp-json\/wp\/v2\/pages\/424\/revisions\/1536"}],"wp:attachment":[{"href":"https:\/\/www.doctaforum-events.org\/2025\/lungcancer2025\/wp-json\/wp\/v2\/media?parent=424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}